Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for GENSF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for GENSF and 80,000+ other tickers.
See exactly how GENSF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for GENSF and 80,000+ other tickers.
Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development. Through its PIC brand, the company supplies breeding pigs and boar semen, enabling the production of swine with specific traits for pork processing. Furthermore, under the ABS, Genus, and Bovec labels, it provides bull semen and bovine embryos to facilitate the breeding of calves with…
Genus PLC (LSE:GNS) said full-year profit is set to beat market expectations after stronger second-half trading and cash proceeds from its Chinese porcine joint venture strengthened the animal genetics group's balance sheet. Adjusted profit before tax for the year ended 30 June is expected to be approximately £98 million, ahead of the company-compiled consensus range of £94.3 million to £96.9 million.
JAIPUR, India, March 2, 2026 /PRNewswire/ -- Genus Power (NSE: GENUSPOWER) (BSE: 530343), India's leading end-to-end energy measurement and advanced metering solutions provider, has crossed a significant milestone of over 26 million smart meter deployment worldwide, reinforcing its position as a trusted technology and execution partner for utilities worldwide. A key driver of this global milestone has been Genus Power's leadership role in India's national grid modernization programme, where the company has now successfully achieved the milestone of installation of over 10 million smart meters as the leading AMI Service Provider.
Genus plc (GENSY) Q2 2026 Earnings Call Transcript
Genus PLC (LSE:GNS) should be a FTSE 100 company by the end of the decade, according to house broker Panmure Liberum. In a recent update, the animal genetics group revealed that trading conditions had remained stronger for longer than anticipated, particularly in the PIC pork division.
Genus PLC (LSE:GNS) has had its price target raised to 3300p from 3100p by Deutsche Bank, which reiterated a 'buy' rating after a pre-close update pointed to continued strong trading in its PIC division. The company reported robust performance at PIC in both China and Latin America in the first half of its 2026 financial year.